Select Page
LA Times: Lumping Marijuana with Heroin is Unreasonable

LA Times: Lumping Marijuana with Heroin is Unreasonable

Marijuana advocates and prohibitionists alike are eagerly awaiting the verdict of a U.S. District Judge’s hearing on the classification of cannabis as a Schedule 1 drug. Being listed as a Schedule I drug under the Controlled Substances Act means that is has no accepted medical value in the United States, among other criteria. It is strange that a plant that has been legalized for medicinal use in nearly half of the United States could remain classified as having no medical value.

The ruling is being made by Federal judge Kimberly J. Mueller from Sacramento, California. Her decision will likely be released later this year.

California’s largest and most influential editorial board at the LA Times has given the judge a boldly worded editorial in the past week.

The piece titled, “Is marijuana really as dangerous as heroin and LSD? Finally, a welcome legal review,” offers encouragement for the future of marijuana’s scheduled status.

This discussion is a welcome one. Whether the Drug Enforcement Administration’s classification is constitutional or not, it shouldn’t take a judge to point out that lumping marijuana in with heroin and deeming it to have no medicinal value at all is unreasonable and unnecessary.

The LA Times editorial recalls the July 2014 New York Times’ editorial board piece where they stated, “The federal government should repeal the ban on marijuana,” and the obvious double standard that currently exist.

Frankly, government policy on marijuana is a mess. Federal law says marijuana has no accepted medicinal value, yet 23 states have legalized it for medical use. It has been put on the list of drugs that carry the most severe penalties for drug crimes, but Congress and the Obama administration have also passed legislation that blocks funding for the enforcement of federal marijuana laws in states that allow medical marijuana.

Continuing their thoughts of recreational marijuana, the editorial reads,

That law, passed in December, in effect ended the prohibition of medical marijuana in nearly half the states. Meanwhile, Colorado and Washington have been unofficially allowed by the federal government to legalize recreational pot.

Culminating with a strong command of their endorsement to reclassify marijuana.

But the country’s drug laws should not be decided in the courts. It’s long past time for Washington to revisit the war on drugs, and officials can begin by reclassifying medical marijuana so it can be regulated more as a prescription drug.

Head over to the LA Times to read the full piece.

H/T [Cannabist]

Doctors’ Group Joins Push for Reclassification of Cannabis

Doctors’ Group Joins Push for Reclassification of Cannabis

In a meeting earlier this month, hundreds of physicians of the Massachusetts Medical Society (MMS) held a meeting to enact new healthcare policies and resolutions concerning eight different topics of public healthcare. One of those resolutions concerned medical marijuana, and a push for the plant to be reclassified on the federal level to ultimately open doors for research. The MMS trade group has publicly stated before that cannabis should be reclassified, and this time their collective voice will be louder.

Currently, cannabis is classified as a Schedule I drug under the Controlled Substances Act. This means that marijuana is seen as having no medical use in the United States. However, nearly half of the United States currently have some form of medical marijuana legislation, so this scheduling is contradictory. Marijuana being listed as a Schedule I drug ultimately blocks researchers from studying the plant and its uses.

Now that Massachusetts also has legalized medical marijuana, physicians want to protect themselves and their patients by conducting studies, and learning as much as possible about the plant. Therefor each individual member of the Massachusetts Medical Society agreed during the interim meeting to write lawmakers advocating for an end to marijuana prohibition. Rick Gulla, society spokesperson told NPR, “The research is fairly thin and it’s a puzzlement for physicians in terms of whether or not they should recommend it.”


photo credit: Coleen Danger

Subscribe To Our Newsletter

Join our mailing list to receive the latest news and updates from our team.

You have Successfully Subscribed!

[data-image-id='gourmet_bg']
[data-image-id='gourmet_bg']
[data-image-id='gourmet_bg']
[data-image-id='gourmet_bg']
[data-image-id='gourmet_bg']
[data-image-id='gourmet_bg']
[data-image-id='gourmet']
[data-image-id='gourmet']
[data-image-id='gourmet']
[data-image-id='gourmet']
[data-image-id='gourmet']
[data-image-id='gourmet']
[data-image-id='gourmet']
[data-image-id='gourmet']
[data-image-id='gourmet']
[data-image-id='gourmet']